These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 21670339

  • 1. Evolution in regression patterns following chemoreduction for retinoblastoma.
    Palamar M, Thangappan A, Shields CL.
    Arch Ophthalmol; 2011 Jun; 129(6):727-30. PubMed ID: 21670339
    [Abstract] [Full Text] [Related]

  • 2. Retinoblastoma regression patterns following chemoreduction and adjuvant therapy in 557 tumors.
    Shields CL, Palamar M, Sharma P, Ramasubramanian A, Leahey A, Meadows AT, Shields JA.
    Arch Ophthalmol; 2009 Mar; 127(3):282-90. PubMed ID: 19273791
    [Abstract] [Full Text] [Related]

  • 3. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors.
    Shields CL, Mashayekhi A, Cater J, Shelil A, Ness S, Meadows AT, Shields JA.
    Arch Ophthalmol; 2005 Jun; 123(6):765-73. PubMed ID: 15955977
    [Abstract] [Full Text] [Related]

  • 4. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients.
    Shields CL, Shelil A, Cater J, Meadows AT, Shields JA.
    Arch Ophthalmol; 2003 Nov; 121(11):1571-6. PubMed ID: 14609913
    [Abstract] [Full Text] [Related]

  • 5. [Retinoblastoma regression patterns and results following chemo reduction and adjuvant therapy].
    Xue K, Qian J, Yue H, Yuan YF, Zhang R.
    Zhonghua Yan Ke Za Zhi; 2012 Jul; 48(7):625-30. PubMed ID: 22943868
    [Abstract] [Full Text] [Related]

  • 6. Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction.
    Demirci H, Eagle RC, Shields CL, Shields JA.
    Arch Ophthalmol; 2003 Aug; 121(8):1125-31. PubMed ID: 12912690
    [Abstract] [Full Text] [Related]

  • 7. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
    Shields CL, Honavar SG, Shields JA, Demirci H, Meadows AT, Naduvilath TJ.
    Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319
    [Abstract] [Full Text] [Related]

  • 8. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K, Günalp I, Yalçindağ N, Unal E, Taçyildiz N, Erden E, Geyik PO.
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [Abstract] [Full Text] [Related]

  • 9. Cavitary changes in retinoblastoma: relationship to chemoresistance.
    Mashayekhi A, Shields CL, Eagle RC, Shields JA.
    Ophthalmology; 2005 Jun; 112(6):1145-50. PubMed ID: 15885779
    [Abstract] [Full Text] [Related]

  • 10. Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors.
    Shields CL, Mashayekhi A, Cater J, Shelil A, Meadows AT, Shields JA.
    Am J Ophthalmol; 2004 Sep; 138(3):329-37. PubMed ID: 15364213
    [Abstract] [Full Text] [Related]

  • 11. Intravenous chemoreduction or intra-arterial chemotherapy for cavitary retinoblastoma: long-term results.
    Rojanaporn D, Kaliki S, Bianciotto CG, Iturralde JC, Say EA, Shields CL.
    Arch Ophthalmol; 2012 May; 130(5):585-90. PubMed ID: 22652844
    [Abstract] [Full Text] [Related]

  • 12. [Clinical therapeutic efficiency of chemoreduction and local therapy for children with retinoblastoma].
    Qian J, Xue K, Gao YJ, Yuan YF, Shan HD, Bi YW.
    Zhonghua Yan Ke Za Zhi; 2010 Apr; 46(4):312-6. PubMed ID: 20654057
    [Abstract] [Full Text] [Related]

  • 13. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors.
    Shields CL, Mashayekhi A, Cater J, Shelil A, Meadows AT, Shields JA.
    Trans Am Ophthalmol Soc; 2004 Apr; 102():35-44; discussion 44-5. PubMed ID: 15747743
    [Abstract] [Full Text] [Related]

  • 14. Regression patterns in treated retinoblastoma with chemotherapy plus focal adjuvant therapy.
    Ghassemi F, Rahmanikhah E, Roohipoor R, Karkhaneh R, Faegh A.
    Pediatr Blood Cancer; 2013 Apr; 60(4):599-604. PubMed ID: 23034769
    [Abstract] [Full Text] [Related]

  • 15. The International Classification of Retinoblastoma predicts chemoreduction success.
    Shields CL, Mashayekhi A, Au AK, Czyz C, Leahey A, Meadows AT, Shields JA.
    Ophthalmology; 2006 Dec; 113(12):2276-80. PubMed ID: 16996605
    [Abstract] [Full Text] [Related]

  • 16. [Results of combined chemoreduction and local treatment for intraocular retinoblastoma].
    Kobylarz J, Piwowarczyk A, Romanowska-Dixon B, Balwierz W, Dłuzniewska A.
    Klin Oczna; 2006 Dec; 108(1-3):55-9. PubMed ID: 16883942
    [Abstract] [Full Text] [Related]

  • 17. Comparison of retinoblastoma reduction for chemotherapy vs external beam radiotherapy.
    Sussman DA, Escalona-Benz E, Benz MS, Hayden BC, Feuer W, Cicciarelli N, Toledano S, Markoe A, Murray TG.
    Arch Ophthalmol; 2003 Jul; 121(7):979-84. PubMed ID: 12860801
    [Abstract] [Full Text] [Related]

  • 18. Post-chemoreduction cryptic optic nerve relapse in a patient with bilateral retinoblastoma.
    Shetye NG, Mataftsi A, Maeder P, Moulin AP, Gaillard MC, Balmer A, Popovic MB, Munier FL.
    Br J Ophthalmol; 2013 Feb; 97(2):233, 245-6. PubMed ID: 23172878
    [No Abstract] [Full Text] [Related]

  • 19. Clinical outcome and regression patterns of retinoblastoma treated with systemic chemoreduction and focal therapy: A prospective study.
    Chawla B, Jain A, Seth R, Azad R, Mohan VK, Pushker N, Ghose S.
    Indian J Ophthalmol; 2016 Jul; 64(7):524-9. PubMed ID: 27609166
    [Abstract] [Full Text] [Related]

  • 20. Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy.
    Shields CL, Shields JA.
    Curr Opin Ophthalmol; 2010 May; 21(3):203-12. PubMed ID: 20224400
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.